Huadong Li
Wuhan, 430023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Multi-cohort study on cytokine and chemokine profiles in the progression of COVID-19.
Journal: Scientific reports
Published: January 09, 2024
Omicron breakthrough infections after triple-dose inactivated COVID-19 vaccination: A comprehensive analysis of antibody and T-cell responses.
Journal: Immunology
Published: November 05, 2023
Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset.
Journal: Frontiers in immunology
Published: May 12, 2021
No significant benefit of moderate-dose vitamin C on severe COVID-19 cases.
Journal: Open medicine (Warsaw, Poland)
Published: March 22, 2021
Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China.
Journal: Journal of ethnopharmacology
Published: December 31, 2020
The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice.
Journal: Journal of cardiovascular translational research
Published: December 07, 2020
ANDC: an early warning score to predict mortality risk for patients with Coronavirus Disease 2019.
Journal: Journal of translational medicine
Published: May 08, 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Journal: Lancet (London, England)
Published: April 13, 2020
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Journal: The New England journal of medicine
Published: March 19, 2020
Last Updated: 09/26/2026